Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2003
05/15/2003US20030091667 Clear, colorless solution; mixture of surfactant and microbiocide
05/15/2003US20030091658 Herbal pharmaceutical composition for treatment of HIV/AIDS patients
05/15/2003US20030091654 Dietetics, antidiabetic agents; using chromium complex
05/15/2003US20030091651 Oil homogenized with sterols; protective coating for stomach
05/15/2003US20030091650 Ratite oil as a topical adjuvant and transdermal carrier
05/15/2003US20030091648 Hydrophilic core overcoated with hydrophobic hot melt lipid; for water soluble vitamins
05/15/2003US20030091645 Organic compounds
05/15/2003US20030091644 Low concentration of peroxide for treating or preventing vaginal infections
05/15/2003US20030091643 Amorphous mixture of acid sensitive drug and addition polymer; chemical resistance, stability
05/15/2003US20030091642 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof
05/15/2003US20030091640 Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents
05/15/2003US20030091639 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
05/15/2003US20030091636 Antiinflammatory agents; uniform dissolving; oral bioavailability
05/15/2003US20030091635 Sustained release; reduced tendency to drug abruse
05/15/2003US20030091633 Pure form; cardiovascular disorders; side effect reduction
05/15/2003US20030091630 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/15/2003US20030091626 Dispersion, ejection melt containing sugar; controlling temperature; solvent-free; freeze drying
05/15/2003US20030091625 Method and device for producing compression coated tablets
05/15/2003US20030091623 Solid oral dosage form containing an enhancer
05/15/2003US20030091621 Encapsulated drugs
05/15/2003US20030091620 Transdermal drug delivery systems containing quaternary ammonium salts and methods of using the same
05/15/2003US20030091587 Bactericides, fungicides, viricides
05/15/2003US20030091582 Autoimmune diseases; antitumor agents; antiallergens
05/15/2003US20030091561 Anticancer agents
05/15/2003US20030091559 Biocompatibility; liquid phase
05/15/2003US20030091558 Storage-stable fibrinogen solutions
05/15/2003US20030091552 Nutraceutical composition
05/15/2003US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders
05/15/2003US20030091540 Uniform spreading into body cavities
05/15/2003US20030091538 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
05/15/2003US20030091519 Synergistic mixture of organosulfur compound and urea; intensify penetration
05/15/2003US20030091518 Mixture containing plant extracts and oils
05/15/2003US20030091517 Andrographis paniculata gel as an adjunct in the treatment of periodontitis
05/15/2003US20030090017 Manikin and eye device apparatus, methods and articles of manufacture
05/15/2003US20030089369 Pressurised metered dose inhalers (MDI)
05/15/2003CA2474196A1 Topical use of cytokines and/or chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
05/15/2003CA2472055A1 Improved mucosal vaccines and methods for using the same
05/15/2003CA2466492A1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003CA2466443A1 Selective treatment of il-13 expressing tumors
05/15/2003CA2466425A1 Photodynamic therapy for the treatment of hair loss
05/15/2003CA2466356A1 Isotopically coded affinity marker 2
05/15/2003CA2466335A1 Surface coated capsules
05/15/2003CA2466319A1 Isotope-coded affinity tag
05/15/2003CA2466303A1 Selective targeting of apoptotic cells
05/15/2003CA2466232A1 Systems for delivery and release of angiotensin-(1-7)
05/15/2003CA2466061A1 Oral adhering and dissolving disc made by deposition with licorice extract
05/15/2003CA2466049A1 Human monoclonal antibodies to dendritic cells
05/15/2003CA2466030A1 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003CA2466027A1 Branched polymers and their conjugates
05/15/2003CA2465981A1 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003CA2465945A1 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003CA2465756A1 Compositions containing oils having a specific gravity higher than the specific gravity of water
05/15/2003CA2465753A1 Orodispersible tablet having high homogeneity and the preparation method thereof
05/15/2003CA2465700A1 Solid oral compositions
05/15/2003CA2465496A1 Oral controlled release forms useful for reducing or preventing nicotine cravings
05/15/2003CA2465159A1 Process for preparing quick dissolving, high loading ribavirin compositions
05/15/2003CA2465110A1 Tamsulosin tablets
05/15/2003CA2463942A1 Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
05/14/2003EP1310517A1 Lactic acid polymer and process for producing the same
05/14/2003EP1310259A2 Formulation comprising a biphosphonate and an absorption enhancing agent for the treatment of osteoporosis
05/14/2003EP1310254A1 Medicinal compositions containing camptothecin derivative and ph regulating agent
05/14/2003EP1310253A1 Niacin-containing sustained-release tablets and kits
05/14/2003EP1310252A1 Injections
05/14/2003EP1310248A1 Pharmaceutical composition
05/14/2003EP1310244A2 Compositions comprising an anticancer agent and a polyether block copolymer
05/14/2003EP1310174A1 Taste-improving agent
05/14/2003EP1309718A2 Neutrokine-alpha and neutrokine-alpha splice variant
05/14/2003EP1309705A2 Multivalent target binding protein
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309616A1 Integrin binding motif containing peptides and methods of treating skeletal diseases
05/14/2003EP1309553A1 New aporphine esters and their use in therapy
05/14/2003EP1309532A1 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof
05/14/2003EP1309369A1 Electro-powder
05/14/2003EP1309355A1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties
05/14/2003EP1309354A2 Therapeutic polyesters and polyamides
05/14/2003EP1309353A2 Flavone-containing plant extract solutions having improved storage and heat stability
05/14/2003EP1309352A1 Antifungal ketoconazole composition for topical use
05/14/2003EP1309351A1 Dermatological formulation
05/14/2003EP1309347A2 Method and composition for altering a b cell mediated pathology
05/14/2003EP1309344A1 Oral solid dose vaccine
05/14/2003EP1309330A1 Photosensitizers with ligand targeting properties for tumor therapy
05/14/2003EP1309327A2 Pharmaceutical compositions of estrogenic agents
05/14/2003EP1309318A1 Consumable container
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1309315A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
05/14/2003EP1309313A1 Composite material and process for increasing bioavailability and activity of a beneficial agent
05/14/2003EP1309312A2 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
05/14/2003EP1309309A1 Dermatological composition
05/14/2003EP1309279A1 Sutures and coatings made from therapeutic absorbable glass
05/14/2003EP1267940B1 Compounds for targeting
05/14/2003EP1137399B1 Improvements in or relating to powders
05/14/2003EP1051194B1 Process for making absorbable microparticles
05/14/2003EP1041996A4 Keratinocyte growth factor-2 formulations
05/14/2003EP1021194B1 New improved formulation for treatment of osteoporosis
05/14/2003EP0817617B1 Microcapsules of predetermined peptide(s) specificity(ies), their preparation and uses
05/14/2003EP0813541B1 Process for producing a protein
05/14/2003EP0800383B1 Pharmaceutical compositions comprising proliposome powders for inhalation
05/14/2003EP0794788B1 Hepatic-directed compounds and reagents for preparation thereof
05/14/2003EP0794783B1 Cyclodextrins as suspending agents for pharmaceutical suspensions
05/14/2003EP0749308B1 Film coated tablet of paracetamol and domperidone
1 ... 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 ... 1712